CytomX Therapeutics Stock (NASDAQ: CTMX) stock price, news, charts, stock research, profile.
Open | $1.610 |
Close | - |
Volume / Avg. | 59.985K / 916.526K |
Day Range | 1.595 - 1.636 |
52 Wk Range | 1.040 - 2.855 |
Market Cap | $110.064M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 4.95% |
Days to Cover | 3.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CytomX Therapeutics (NASDAQ: CTMX) through any online brokerage.
Other companies in CytomX Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Barinthus Biotherapeutics (NASDAQ:BRNS), FibroGen (NASDAQ:FGEN) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for CytomX Therapeutics (NASDAQ: CTMX) was reported by JP Morgan on Monday, April 22, 2024. The analyst firm set a price target for 0.00 expecting CTMX to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $1.625 last updated Today at April 25, 2024 at 11:03 AM EDT.
There are no upcoming dividends for CytomX Therapeutics.
CytomX Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for CytomX Therapeutics.
CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.